Neuberger Berman Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $217K | Hold |
|
|||||
|
2021
Q4 | $249K | Sell |
|
|||||
|
2021
Q3 | $265K | Sell |
|
|||||
|
2021
Q2 | $305K | Hold |
|
|||||
|
2021
Q1 | $292K | Hold |
|
|||||
|
2020
Q4 | $277K | Sell |
|
|||||
|
2020
Q3 | $226K | Hold |
|
|||||
|
2020
Q2 | $233K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $223K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $214K | Hold |
|
|||||
|
2019
Q1 | $221K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $238K | Hold |
|
|||||
|
2018
Q2 | $219K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $231K | Hold |
|
|||||
|
2016
Q3 | $250K | Hold |
|
|||||
|
2016
Q2 | $220K | Hold |
|
|||||
|
2016
Q1 | $228K | Hold |
|
|||||
|
2015
Q4 | $301K | Sell |
|
|||||
|
2015
Q3 | $346K | Hold |
|
|||||
|
2015
Q2 | $442K | Hold |
|
|||||
|
2015
Q1 | $418K | Hold |
|
|||||
|
2014
Q4 | $380K | Hold |
|
|||||
|
2014
Q3 | $350K | Sell |
|
|||||
|
2014
Q2 | $364K | Buy |
|